CD8-IL21

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCD8-IL21
Drug Alias NameCD-8-IL-21CD8-IL21
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-21 inhibitorsCluster of differentiation 8 stimulants
TargetsCluster of differentiation 8Interleukin-21
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States Minor Outlying Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsher Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAsher Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A